Evidence map›Paper›PMID 40182523›Full record

ArticleFrontiers in public health2025

Research on the evolution of biotechnology cooperation networks - a study based on patent data in China from 2004 to 2023.

Chongfeng Wang, Yifei Wang, Linfeng Zhong, Jie Xu

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chongfeng WangBusiness School, Qingdao University, Qingdao, China.
Yifei WangSchool of Mathematic and Statistics, Qingdao University, Qingdao, China.
Linfeng ZhongBusiness School, Qingdao University, Qingdao, China.
Jie XuBusiness School, Qingdao University, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Biotechnology has significant potential in public health, offering critical support for communicable disease control, chronic illness management, and drug development. To foster biotechnology innovation, governments increasingly incentivize cooperations among organizations, resulting in more interconnected biotechnology cooperation networks. However, research on the evolution of these networks rely primarily on static network analysis and neglect the micromechanisms under the evolution, which lead to deviations in policymaking. Methods: Using temporal exponential random graph model (TERGM), which accounts for dynamic network correlations, and based on micromechanisms framework consisting of agency, opportunity and inertia, this study analyzes the impacts of both endogenous and exogenous factors on the evolution of biotechnology cooperation networks. Results: The empirical analysis based on China's biotechnology patent data from 2004 to 2023 reveals the following findings and policy recommendations. First, the evolution of the biotechnology cooperation networks is temporally dependent, highlighting the need for awareness of policy lags. Second, two endogenous factors - transitivity and convergence - emerge in the evolution, implying the need for government to create information platforms, establish targeted project subsidies, and enforce technical confidentiality policies. Finally, with regard to exogenous factors, the networks exhibit geographical homogeneity, implying the needs for government to promote cross-regional cooperation by establishing innovation centers and unified standards to mitigate lock-in effects and barriers.

Indexed as

BiotechnologyCooperative BehaviorPatents as TopicChinaHumansbiotechnology cooperation networksendogenous factorsexogenous factorsmicromechanismsnetworks evolutionTERGMtime dependence

Identifiers

PMID40182523
PMCPMC11966448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.